Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

61 results about "Trabecular meshwork" patented technology

The trabecular meshwork is an area of tissue in the eye located around the base of the cornea, near the ciliary body, and is responsible for draining the aqueous humor from the eye via the anterior chamber (the chamber on the front of the eye covered by the cornea).

Capsid protein mutant capable of improving infection ability of AAV to eye tissues and application of capsid protein mutant

ActiveCN119080889AImprove infection abilitySenses disorderGenetic material ingredientsDiseaseRetinal
The invention belongs to the technical field of biology, and discloses a capsid protein mutant capable of improving the infection ability of AAV to eye tissues and application of the capsid protein mutant. AAVRFDGTERAA and RQYSDAVRAE are inserted into amino acid at the 587 site and amino acid at the 588 site, which are equivalent to that of wild type AAV2 virus capsid protein, so that capsid protein mutants AAV2-NE01 and AAV2-NE02 are obtained. The virus yield of AAV2-NE01 and AAV2-NE02 is 1.96 times and 1.20 times that of AAV2-WT, after intravitreal injection, cells and trabecular meshwork areas of NHP retina GCL, INL to ONL can be well infected, the infection positive rate is high, the fluorescence intensity is high, the penetrating power to the retina is high, and visual cell nucleuses and inner segments can be infected. The AAV vector has a good application prospect and is expected to be developed into the AAV vector for treating eye diseases.
Owner:GUANGZHOU YIMAGENE TECHNOLOGY CO LTD

Ophthalmic knife and methods of use

The present invention relates to an ophthalmic knife and methods of its use for treatment of various conditions including eye diseases, such as glaucoma, using minimally invasive surgical techniques. The device is configured for cutting the tissues within the eye, for example, a trabecular meshwork (TM).
Owner:NEW WORLD MEDICAL INC +1

Ophthalmic surgery instrument, intraocular excision member, and manufacturing method therefor

Provided is an ophthalmic surgery instrument that allows an instrument suitable for excising a trabecular meshwork to be configured and allows a grip portion to be used for both first ophthalmic surgery such as trabeculectomy and second ophthalmic surgery. A first passage and a second passage for performing suction or supply of a perfusate are formed in a grip portion of an ophthalmic surgery instrument. An internal thread portion is formed at a tip end of the grip portion. A tip end member for first ophthalmic surgery has a single passage therein, and has a bent-shaped blade portion and an opening of the passage at a tip end thereof. The tip end member for first ophthalmic surgery and a tip end member for second ophthalmic surgery are selectively screwable to the internal thread portion.
Owner:TRABECTOR CO INC

Application of sophora flavescens ethyl acetate part and active component thereof in resisting glaucoma trabecular network fibrosis

The invention discloses an application of a sophora flavescens ethyl acetate part and an active component thereof in resisting glaucoma trabecular meshwork fibrosis, relates to the field of biological medicines, and innovatively discovers the effect of the sophora flavescens ethyl acetate part and the active component thereof in resisting glaucoma trabecular meshwork fibrosis. The compound can be applied to preparation of drugs for resisting trabecular meshwork cell fibrosis and preventing and treating trabecular meshwork cell fibrosis related diseases such as glaucoma.
Owner:GUIZHOU MEDICAL UNIV

Wellness Device for Eyes

PendingUS20250041152A1Vibration massageEyelid surfaceTrabecular meshwork
A method and device for mechanically stimulating the trabecular meshwork of an eye is disclosed. The device acts non-invasively to vibrate a closed eyelid on areas which are in close proximity to the trabecular meshwork, which is located in tissues below the closed eyelid. The vibration at the surface of the eyelid induces mechanical vibratory waves which conduct through the tissues of and around they eye, causing the movement and deformation of the trabecular meshwork. This action results in clearing the trabecular meshwork of substances, such as debris, which may accumulate in the open-cell pores of, and on the structural surfaces of, the trabecular meshwork. If not cleared, such substances debris can increase the resistance to the healthy outflow of fluid from the eye which elevates the intraocular pressure and can lead to serious health problems, especially glaucoma.
Owner:LARSON MICHAEL CHARLES

Femtosecond laser assisted room corner cutting device

The invention discloses a femtosecond laser assisted room corner cutting device which comprises a placing table, a femtosecond laser generator is arranged on one side of the placing table, a slit lamp microscope is placed on the placing table, a bracket is arranged on the placing table, the bracket is arranged in the direction right opposite to the slit lamp microscope, and the bottom end of the placing table is connected with a bottom frame through a telescopic supporting column. Notches are formed in the sides, close to the slit-lamp microscope and the bracket, of the bottom frame, an adjuster is arranged on the placing table, the slit-lamp microscope is connected with the femtosecond laser generator through a circuit, and the adjuster is arranged on the circuit; through combination of the femtosecond laser generator and the slit lamp microscope, the chamber angle incision operation is simplified, even if a traditional incision chamber angle incision operation (also known as intranet trabecular meshwork incision operation) is changed into an incision-free laser operation, the operation infection risk is reduced, the chamber angle incision operation can be transferred to a hospital outpatient service from an original operating table, and the operation efficiency is improved. And medical resources and human resources are greatly saved.
Owner:SHENZHEN EYE HOSPITAL

Optical coherence tomography (OCT) fiber probe for guiding glaucoma surgery

PCT designated stageWO2026053124A1Laser surgerySurgeryTomographyReoperative surgery
A system includes a light source configured to emit treatment light and an optical coherence tomography (OCT) device. The system further includes a surgical instrument including a distal portion configured to be inserted into an eye of a patient. An optical fiber is coupled to the light source and to the OCT device and (a) conducts the treatment light along the distal portion to be emitted from a tip of the distal portion and (b) conducts detection light from the OCT device along the distal portion to be emitted from the tip of the distal portion and conduct a reflected portion of the detection light to the OCT device. A controller obtains image data from the OCT device and operates the light source per the image data, e.g., selects a number of pulses for the treatment light based on a thickness of a trabecular meshwork apparent in the image data.
Owner:ALCON INC

Transscleral laser

PendingCN121693314ALaser surgerySurgical instrument detailsCiliary epitheliumCiliary crown
The present disclosure describes an optical probe for applying a laser light to at least the flat portion of the ciliary body and optionally other areas, such as the trabecular mesh, the ciliary crown and / or the ciliary sulcus of the eye, the present invention relates to methods, such as for treating glaucoma, reducing intraocular pressure (IOP), improving the outflow of aqueous humor from the eye, and / or reducing the accumulation of aqueous humor within the eye. The optical probe may be adapted for simultaneous treatment of a plurality of different regions, tissues, or eye bodies of the eye, or for sequential treatment of a plurality of different regions, tissues, or eye bodies of the eye.
Owner:NATIONAL UNIVERSITY OF SINGAPORE +1

Ophthalmic knife and methods of use

An ophthalmic knife for treatment of various conditions including eye diseases, such as glaucoma, using minimally invasive surgical techniques is provided. The ophthalmic knife includes a shaft, a first platform connected to an end of the shaft and extending at an angle from a longitudinal axis of the shaft and a second platform connected to the shaft adjacent to the first platform. The first platform includes a first top surface extending from a first tip and a first bottom surface opposing the first top surface, and the second platform includes a second top surface extending from a second tip, and a second bottom surface opposing the second top surface. The first platform severs trabecular meshwork in a human eye as the trabecular meshwork advances over the first top surface of the first platform and the second bottom surface of the second platform engages but does not sever the trabecular meshwork.
Owner:THE REGENTS OF THE UNIVERSITY OF COLORADO +1

Method for constructing an animal model of open-angle glaucoma

The present disclosure pertains to the field of animal disease models, specifically to a method for constructing an animal model of open-angle glaucoma. In this model, the pathogenesis of open-angle glaucoma is mimicked by inducing necroptosis in trabecular meshwork cells through the injection of IFN-γ into the anterior chamber. This process leads to the inhibition of trabecular meshwork activity and functional impairment, resulting in elevated intraocular pressure and subsequent optic nerve changes indicative of glaucoma. The pathophysiological alterations observed in the animal model closely resemble those seen in human open-angle glaucoma, including chamber angle opening, trabecular meshwork dysfunction, increased intraocular pressure, and loss of RGCs.
Owner:THE SECOND XIANGYA HOSPITAL OF CENT SOUTH UNIV

Application of umbilical cord blood exosome in preparation of medicine for treating ophthalmic diseases caused by aging

The invention discloses application of an umbilical cord blood exosome in preparation of a medicine for treating ophthalmic diseases caused by aging. It is found that the umbilical cord blood exosome can improve the biological characteristics of senescent trabecular meshwork cells, relieve the senescence characteristics of the trabecular meshwork cells, improve the DNA damage repair capacity of the cells, promote proliferation of the trabecular meshwork cells and effectively maintain the stability of cell nucleuses, and then growth and division of the cells are supported. The umbilical cord blood exosome shows a remarkable anti-aging effect in treatment of ophthalmic diseases caused by aging, can effectively improve the biological function of trabecular meshwork cells, slow down the aging process and promote cell proliferation and repair, and has wide application potential.
Owner:MONONUCLEAR THERAPEUTICS LTD

Ophthalmic surgery instrument, intraocular excision member, and manufacturing method therefor

Provided is an ophthalmic surgery instrument that allows an instrument suitable for excising a trabecular meshwork to be configured and allows a grip portion to be used for both first ophthalmic surgery such as trabeculectomy and second ophthalmic surgery. A first passage and a second passage for performing suction or supply of a perfusate are formed in a grip portion of an ophthalmic surgery instrument. An internal thread portion is formed at a tip end of the grip portion. A tip end member for first ophthalmic surgery has a single passage therein, and has a bent-shaped blade portion and an opening of the passage at a tip end thereof. The tip end member for first ophthalmic surgery and a tip end member for second ophthalmic surgery are selectively screwable to the internal thread portion.
Owner:TRABECTOR CO INC

A pathological biopsy needle for trabecular meshwork tissue of the eye

This invention relates to a biopsy needle for trabecular meshwork tissue of the eye, belonging to the field of medical device technology. It solves the problem of large incisions caused by the large surgical incisions in traditional trabeculectomy procedures, where a scalpel is used to cut a block of ocular tissue containing the trabeculae and deep cornea and sclera. The invention includes a needle, a scraper unit, and a handle. The needle is connected to the handle, the scraper unit is disposed within the needle, and the handle is for the user to hold. The needle is inserted into the patient's eyeball, and the scraper unit is used to cut the trabecular meshwork and Schlemm's canal wall tissue. The scraper unit of this invention is a bendable scraper unit. The first, second, and third sections can form grooved hooks for hooking the trabecular meshwork and Schlemm's canal wall tissue. The grooved hooks of this invention are specifically designed to hook the trabecular meshwork and Schlemm's canal wall tissue, resulting in minimal trauma to the ocular incision.
Owner:PEKING UNIVERSITY THIRD HOSPITAL (THE THIRD CLINICAL MEDICAL SCHOOL OF PEKING UNIVERSITY)

An intraocular implant delivery device

The present invention discloses an intraocular implant delivery device, which includes a housing, a main control pull rod assembly, a slider assembly, a striking assembly, a needle retracting turntable and a needle pushing assembly. The main control pull rod assembly, the slider assembly, the striking assembly and the needle retracting turntable are all arranged inside the housing. A through hole is provided at the distal end of the housing, and the needle of the needle pushing assembly passes through the through hole and extends to the outside of the housing. Energy sources capable of selectively releasing energy are arranged on the main control pull rod assembly, the slider assembly and the striking assembly; the main control pull rod assembly is actuated by an operator through a button arranged on the housing, so that a spring drives the main control pull rod assembly to move axially; for the intraocular implant delivery device of the present invention, only one puncture is required to repeatedly deliver implants to the trabecular meshwork of a patient for multiple times, improving the efficiency of the implant surgery and enabling higher implant accuracy of the implants; the present invention can effectively overcome the problems of empty firing of implants or firing two implants at a time caused by low grasping accuracy of the needle pushing.
Owner:HEALTH GUARD (SUZHOU) BIOMED TECH CO LTD

Pathological biopsy needle for eye trabecular meshwork tissue

The invention relates to a pathological biopsy needle for eye trabecular meshwork tissue, belongs to the technical field of medical instruments, and solves the problem that in the traditional trabectomy in the prior art, an eye tissue block containing trabecula and deep sclera is cut by a surgical blade, and the trauma of an eye incision is large. The device comprises a needle head, a scraper unit and a handle, the needle head is connected with the handle, the scraper unit is arranged in the needle head, the handle is used for being held by a user, the needle head is used for being inserted into an eyeball of a patient, and the scraper unit is used for cutting trabecular mesh and Schlemm tube wall tissue. The scraper unit is a bendable scraper unit, the first section, the second section and the third section can form a hook part with a groove, and the hook part with the groove is used for hooking trabecular meshes and Schlemm pipe wall tissues. The hook part with the groove is specially aligned to trabecular meshes and Schlemm tube wall tissues for hooking, and the trauma of an eye incision is small.
Owner:PEKING UNIVERSITY THIRD HOSPITAL (THE THIRD CLINICAL MEDICAL SCHOOL OF PEKING UNIVERSITY)

Application of reagent for inhibiting STAT3 gene expression in treatment of oxidative damage of trabecular meshwork cells

The invention relates to application of a reagent for inhibiting STAT3 gene expression in treatment of oxidative damage of trabecular meshwork cells. According to the invention, a signal channel STAT3 to EIF4E to TGF-beta-SMAD < 2 / 3 > for regulating and controlling the oxidative damage of the trabecular meshwork cells is innovatively found, and the STAT3 activates the TGF-beta-SMAD < 2 / 3 > channel by combining with EIF4E3, so that the apoptosis, oxidative stress and fibrosis of the trabecular meshwork cells caused by the oxidative damage are promoted. After the expression of the STAT3 gene in trabecular meshwork cells is inhibited, the EIF4E3 level can be reduced, and the apoptosis, oxidative stress and fibrosis of the trabecular meshwork cells induced by EIF4E3 are improved. Therefore, a reagent for inhibiting STAT3 gene expression can be used for treating trabecular meshwork cell oxidative damage and eye diseases related to the trabecular meshwork cell oxidative damage, including glaucoma and the like.
Owner:HENAN PROVINCIAL EYE HOSPITAL (HENAN PROVINCIAL EYE INST)

Laser therapy for treatment and prevention of eye diseases

An ab externo automated laser treatment system for treating an eye in a subject, includes a non-contact laser source configured to generate a laser beam having at least one wavelength to treat the eye by directing the laser beam from a location spaced from the eye, wherein the at least one wavelength is a near-infrared wavelength in the range of about 0.5-2.2 μm, a laser scanner optically coupled to the non-contact laser source to receive the laser beam from the non-contact laser source and to scan the laser beam relative to the eye, and a processor, and memory including stored computer-readable instructions that, responsive to execution by the processor, cause the laser treatment system to direct the laser beam to a plurality of trans-scleral treatment locations to be irradiated in a predetermined treatment pattern on an external surface of the eye, wherein the trans-scleral treatment locations are 0-4 mm posterior to the corneolimbal junction, and wherein the laser beam is repetitively directed to the same irradiated trans-scleral treatment locations on the surface of the eye, and the trans-scleral treatment locations are irradiated at intervals sufficient to induce protective thermal preconditioning and therapeutic bio-stimulation of one or more of the trabecular meshwork and / or ciliary body without photocoagulation of the tissue of the eye. Trans-pupillary systems, patient interfaces, and methods are also disclosed.
Owner:ALEYEGN TECH LLC

An engineered exosome containing an antibody

This invention belongs to the field of biomedical technology, specifically relating to an engineered exosome and its applications. This invention is the first to discover that PCDH12 is specifically highly expressed in the trabecular meshwork tissue of glaucoma patients. Based on this target, engineered exosomes loaded with PCDH12 antibodies were successfully developed. These engineered exosomes can achieve non-invasive and precise targeted delivery to the trabecular meshwork tissue. In glaucoma model mouse experiments, they not only significantly reduced intraocular pressure but also effectively protected the optic nerve. The non-invasive and precise delivery strategy proposed in this invention combines potent intraocular pressure reduction with direct neuroprotection, providing a candidate solution with direct clinical translational potential for integrated "pressure reduction-neuroprotection" treatment of glaucoma.
Owner:EYE INST OF SHANDONG FIRST MEDICAL UNIV

Ophthalmic surgery instrument

Provided is an ophthalmic surgery instrument that allows an instrument suitable for excising a trabecular meshwork to be configured and allows a grip portion to be used for both first ophthalmic surgery such as trabeculectomy and second ophthalmic surgery. A first passage 7 and a second passage 8 for performing suction or supply of a perfusate are formed in a grip portion 2 of an ophthalmic surgery instrument 1. An internal thread portion 9 is formed at a tip end of the grip portion 2. A tip end member 3 for first ophthalmic surgery has a single passage 13 therein, and has a bent-shaped blade portion 16 and an opening 14 of the passage 13 at a tip end thereof. The tip end member 3 for first ophthalmic surgery and a tip end member 30 for second ophthalmic surgery are selectively screwable to the internal thread portion 9.
Owner:TRABECTOR CO INC

Direct laser trabeculoplasty method and apparatus

PendingJP2025188176ALaser surgeryInterferometersLaser trabeculoplastyAqueous humor
To provide apparatus and methods for treating glaucoma in a patient's eye (25).SOLUTION: A treatment laser beam is directed at the trabecular meshwork of the patient's eye to initiate reactions that promote improved drainage of aqueous humor fluid.SELECTED DRAWING: Figure 3a
Owner:ELLEX MEDICAL

Capsid protein mutants that enhance the infectivity of AAV to ocular tissues and their applications

ActiveCN119080889BSenses disorderVirus peptidesGanglion cell layerDisease
The present invention belongs to the field of biotechnology, and discloses a capsid protein mutant that improves the infectivity of AAV to eye tissues and its application. By inserting AAVRFDGTERAA and RQYSDAVRAE at amino acid positions 587 and 588 corresponding to the wild-type AAV2 virus capsid protein, the capsid protein mutants AAV2-NE01 and AAV2-NE02 are obtained. The virus yields of AAV2-NE01 and AAV2-NE02 are 1.96 times and 1.20 times that of AAV2-WT. After intravitreal injection, they can preferably infect various layers of cells from the ganglion cell layer (GCL), inner nuclear layer (INL) to outer nuclear layer (ONL) of the NHP retina and the trabecular meshwork region, with a high infection positive rate, strong fluorescence intensity, strong retinal penetration ability, and can infect the nuclear part and inner segment of the optic nerve. It has good application prospects and is expected to be developed into an AAV vector for treating eye diseases.
Owner:GUANGZHOU YIMAGENE TECHNOLOGY CO LTD

Ophthalmic knife

ActiveCN115461019BEye surgeryOphthalmic knifeOPHTHALMOLOGICALS
Owner:THE REGENTS OF THE UNIVERSITY OF COLORADO +1

Modular intraocular implant for vitrectomy

PCT designated stage expiredWO2025017501A1SurgeryIntraocular lensCiliary epitheliumVitrectomy procedure
An apparatus for implant into an eye. The apparatus may comprise a receptacle configured to receive an optic; a flange circumscribing the receptacle, the flange configured to be disposed in the ciliary sulcus of the eye; and a fenestration through the flange, the fenestration configured to allow aqueous humor to pass anteriorly from the ciliary body to the trabecular meshwork of the eye. Some or all of the apparatus may have an oleophobic coating. For example, some embodiments of the flange may have an oleophobic coating. In some embodiments, the fenestration may be inferior to the receptacle. Additionally, or alternatively, the apparatus may further comprise at least two haptics coupled to the flange.
Owner:ALCON INC

Capsid protein mutants capable of increasing ability of aavs to infect ocular tissue and use thereof

PCT designated stage expiredWO2025051292A9Senses disorderGenetic material ingredientsMouse RetinaPrimate
Capsid protein mutants capable of increasing the ability of AAVs to infect ocular tissue and the use thereof. A Cap mutant is obtained by replacing an amino acid sequence of an AAV capsid protein which is homologous to amino acids at positions D561 to R588 of a wild-type AAV2 capsid protein with one of the polypeptides as shown in SEQ ID NOs. 6-39. Some Cap mutants can infect a mouse retina from the RGC layer, cone and rod cells of INL and ONL, corneal limbus regions, trabecular meshwork, RPE and a small amount of RPE cells by administration via intravitreous injection, can solve the problem that it is difficult for the conventional serotype AAV to infect the cells in the posterior layer of the retina due to insufficient penetrability, and is expected to become a potential carrier for the treatment of glaucoma. Experimental data show that the abilities of some Cap mutants to infect and penetrate the retina of non-human primates are optimized, thereby providing a new tool for developing gene therapy preparations for ophthalmic diseases or constructing animal models related to ophthalmic diseases.
Owner:GUANGZHOU YIMAGENE TECHNOLOGY CO LTD

Soluble microneedle patch for in-situ drug delivery of trabecular meshwork tissue as well as preparation method and application of soluble microneedle patch

The invention belongs to the technical field of biological medicine, and particularly relates to a soluble microneedle patch for in-situ drug delivery of trabecular meshwork tissue and a preparation method and application of the soluble microneedle patch. The soluble microneedle patch comprises a fan-ring-shaped backing and a microneedle array arranged on the fan-ring-shaped backing; the micro-needle and the fan-ring-shaped backing are both prepared from polyvinyl alcohol (PVA), the PVA concentration for preparing the micro-needle and the fan-ring-shaped backing is 5%-25%, and the PVA concentration is obtained by weighing 0.5 g-2. 5 g of PVA powder and dissolving the PVA powder in 10 mL of pure water or PBS. The microneedle patch is suitable for delivery of various types of drugs, is expected to be used for treatment of various eye diseases including glaucoma, ocular hypertension, cataract, uveitis, conjunctivitis, xerophthalmia and the like, and has important clinical application value and commercial value.
Owner:THE EYE HOSPITAL OF WENZHOU MEDICAL UNIVERSITY

Application of 6-C-(E-styryl)-naringenin in preparation of product for preventing and improving osteoporosis

PendingCN121421173AOrganic active ingredientsSkeletal disorderBone densityDecreased estrogen
The invention discloses an application of 6-CEPN in preparation of a product for preventing and improving osteoporosis. According to the invention, ovariectomized mice are fed with two doses of 6-CEPN, which discovers that the 6-CEPN can obviously inhibit abnormal weight increase of the mice caused by estrogen decrease and can also improve bone microstructure of the ovariectomized mice; the bone trabecula network structure is adjusted by increasing the bone trabecula connection density, the bone trabecula number and the bone trabecula thickness and reducing the separation degree of the bone trabecula, meanwhile, 6-CEPN can further increase the bone density and the bone volume fraction of ovariectomized mice, increase the rigidity and deflection of bones and improve the bone strength, the effect of high-dose 6-CEPN is larger than that of low-dose 6-CEPN, and the effect of high-dose 6-CEPN is better than that of low-dose 6-CEPN. Therefore, the composition has a dose-dependent effect.
Owner:JIANGNAN UNIV

A medicine for treating glucocorticoid-induced glaucoma

The application discloses a kind of drugs for treating glucocorticoid glaucoma.The application finds by experiment, Rho kinase inhibitor can inhibit RhoA-ROCK signal pathway, destroy glucocorticoid-induced cytoskeleton remodeling and reduce extracellular matrix deposition.At the same time, 10 μM or less concentration, no toxic side effects to cell growth, while significantly inhibiting RhoA-ROCK signal pathway.The experimental results suggest that RKI1447 can change the morphology of trabecular meshwork cells and inhibit cell migration, thereby regulating aqueous humor drainage, reducing intraocular pressure, and thereby treating glucocorticoid glaucoma.The application provides the application of Rho kinase inhibitor RKI1447 in the preparation of glucocorticoid glaucoma drugs.
Owner:王腾文 +1

Gene therapy for anterior of eye

The present invention relates to therapies for ocular diseases or disorders in an individual. Provided herein are methods of delivering nucleic acid vectors to ocular cells (e.g., corneal endothelium, trabecular meshwork, etc.) in an anterior segment of an eye involving methods of administering nucleic acid vectors to an individual and methods of electrotransferring nucleic acid vectors to express a therapeutic transgene. Nucleic acid vectors for use in ocular diseases, such as Fukes dystrophy, are also provided.
Owner:ALDEVRON LLC

Transcleral laser

Described are optical probes for application of laser light to at least the pars plana and optionally other regions, such as the trabecular meshwork, pars plicata, and / or ciliary sulcus, of an eye, such as for treatment of glaucoma, to reduce intraocular pressure (IOP), to improve outflow of aqueous humor from the eye, and / or reduce buildup of aqueous humor within the eye. The optical probes can be adapted for simultaneously treating multiple different regions, tissues, or bodies of the eye, or for sequentially treating multiple different regions, tissues, or bodies of the eye.
Owner:NATIONAL UNIVERSITY OF SINGAPORE +1

Application of ferroptosis inhibitor in preparation of medicine for preventing and treating intraocular hypertension

The invention relates to the technical field of biological medicine, in particular to application of a ferroptosis inhibitor in preparation of a medicine for preventing and treating intraocular hypertension. Research finds that the ferroptosis inhibitor can effectively slow down fibrosis of trabecular meshwork cells caused by SiO, and evidence and thought are provided for treating intraocular hypertension caused by SiO filling.
Owner:RUIJIN HOSPITAL AFFILIATED TO SHANGHAI JIAO TONG UNIV SCHOOL OF MEDICINE